Back

5-year results of the complete versus culprit vessel percutaneous coronary intervention in multivessel disease using drug-eluting stents II study. A prospective, randomized controlled trial.

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Long-Term outcomes of PCI PCI: long-term outcome ESC Premium Access ESC Congress 2017

About the speaker

Photo
Mr Nick Daniel Fagel

Noordwest Hospital Group, Alkmaar (Netherlands (The))

14 More presentations in this session

Presentation thumbnail
Predictors of multiple percutaneous coronary interventions in a statewide database of 114,588 patients
Professor J. Kostis (New Brunswick, US)
Abstract Slides
Presentation thumbnail
Landmark analysis of clinical outcome following first-generation vs newer-generation coronary drug-eluting stent implantation: A pooled analysis of SORT OUT III-V studies
Professor M. Maeng (Aarhus, DK)
Abstract Slides
Presentation thumbnail
Bedside PCI risk score.
Doctor L. Wang (Singapore, SG)
Abstract Slides
Presentation thumbnail
Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting: a meta-analysis of patients with left main coronary artery disease
Doctor N. Spinthakis (Torbay, GB)
Abstract Slides
Presentation thumbnail
Post-procedural increase of urinary kidney injury molecule type 1 predicts outcome in patients with coronary artery disease submitted to coronary angiography
Professor M. Wybraniec (Katowice, PL)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Long-Term outcomes of PCI

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources